
James F. McDonough
Of Counsel
732-568-8360 jmcdonough@sh-law.comFirm Insights
Author: James F. McDonough
Date: April 30, 2014

Of Counsel
732-568-8360 jmcdonough@sh-law.comWalgreens, a staple U.S. drugstore, has been headquartered in Illinois for almost a century. The company got its start in downstate Dixon, Ill., before moving its corporate headquarters to Chicago and then eventually to Deerfield, Ill., according to the Chicago Tribune. The company’s next corporate move may take it further away – to Bern, Switzerland.
A group of influential shareholders, including Goldman Sachs Investment Partners and hedge funds Jana Partners, Corvex and Och-Ziff, are reportedly pressuring the company to undergo a so-called “inversion,” according to the Financial Times. This move would allow Walgreens to relocate to Switzerland, paying a dramatically lower corporate income tax rate. The corporate income tax in the U.S. is among the highest in the world – a factor that has prompted a number of companies in the public eye to redomicile their headquarters abroad.
Analysts at UBS found that Walgreens’ tax rate was anticipated to be 37.5 percent this year, according to the news source. This is considerably higher than the tax rate for Alliance Boots, a formerly UK-based pharmacy chain of which Walgreens recently acquired 45 percent. Boots is anticipated to pay a tax rate of only 20 percent as a result of having made such an inversion a few years ago.
UBS explained in a note last month that Walgreens could increase earnings per share by 75 percent by undergoing an inversion, the news source explained. The finance group noted, however, that “Walgreens’ management seems more hesitant to pull the trigger near-term due to perceived political risks.”
Many think that Walgreens is right to be concerned about political risk, particularly because of recent attention paid to corporate tax in the U.S. and the face-to-face nature of the company’s interactions with the public. Inversions have become very popular in the last two years, FT explained, especially in the pharmaceutical sector.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Bringing on outside investors can provide the capital and strategic support a business needs to grow. However, raising capital also introduces important legal, financial, and operational considerations. Before bringing on investors, businesses should address key legal issues to reduce risk, streamline investor due diligence, and position the company for long-term success. Early preparation signals that […]
Author: Dan Brecher

How the Updated Law Shapes Retirement and Estate Planning The SECURE 2.0 Act of 2022 materially reshapes the required minimum distribution (RMD) landscape, extending tax deferral opportunities while accelerating distribution requirements for many beneficiaries. For high-net-worth individuals and families, these changes are not merely technical. They require a reassessment of retirement income strategies, beneficiary planning, […]
Author: Marc J. Comer

Small businesses considering buying commercial property in New Jersey must evaluate a range of legal, financial, and operational factors. While ownership can offer long-term value and control, it also introduces significant risks if not properly structured. This guide outlines key considerations to help New Jersey business owners make informed decisions, minimize legal exposure, and successfully […]
Author: Robert L. Baker, Jr.

On January 28, 2026, staff of the U.S. Securities and Exchange Commission’s Divisions of Corporation Finance, Investment Management, and Trading and Markets issued a joint statement clarifying how existing federal securities laws apply to tokenized securities. The SEC’s “Statement on Tokenized Securities” does not establish new law, but it does provide greater clarity on the […]
Author: Dan Brecher

Operating a business in the New Jersey and New York City metropolitan region offers incredible opportunities, but it also requires navigating a dense and highly regulated legal environment. From entity formation to regulatory compliance, seemingly minor legal oversights can expose business owners to significant risk. In our work with businesses throughout the region, our attorneys […]
Author: Dan Brecher

High-profile founder litigation is more than just a media spectacle. For startup founders, these cases underscore the legal and structural risks that can arise when rapid growth outpaces formal oversight. While launching a new company can be both an exciting and deeply rewarding endeavor, founders must be mindful that it also comes with significant risks. […]
Author: Dan Brecher
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!